Biophysical Assays, Fragment Screening and Science

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biophysical Assays

Fragment Screening

Science

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

APRIL 7, 2025

This stability enables the application of hit identification approaches such as fragment-based screening (FBS). The development of PoLiPa technology marks a new era in membrane protein drug discovery, rendering otherwise difficult targets accessible to structural biology, biophysical assays and other screening technologies.

Fragment Screening

Fragment Screening Drugs Small Molecule Biophysical Assays

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

In terms of compound libraries, we have a high-throughput screening library of about 200,000 ligands. For fragment screening, which are much smaller compounds, we have a library of about 3000 fragments. We can screen with many different formats and modalities.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Drug Discovery Digest

Advancements in hit identification for membrane protein drug discovery

Target-directed cancer: protein-ligand interactions

Webinars

Stay Connected